The International Symposium on IgA Nephropathy is the meeting of the International IgA Nephropathy Network (IIgANN). The conference showcases research on IgAN from across the globe.
Travere at IIgANN 2025
Travere Therapeutics was excited to participate in the 18th International Symposium on IgA Nephropathy and engage with researchers and renal healthcare professionals from around the world. We look forward to seeing you next year.
Program
Sparsentan (SPAR) Added to Stable Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2is) in Adults With IgA Nephropathy (IgAN) in the Phase 2 SPARTACUS Trial
Speakers: Sydney CW Tang, Isabelle Ayoub, Laura Ann Kooienga, Priscila Preciado, David S Lee, Radko Komers, Bruce Hendry, Alex Mercer, Stephanie Moody, Brad H Rovin
Contact your Travere MSL
Our Medical Science Liaisons (MSLs) are available to answer questions and provide support on Travere products.
Contact an MSLSparsentan as First-Line Treatment of Incident Patients With IgA Nephropathy: An Interim Analysis of the SPARTAN Trial Evaluating Efficacy and Cardiovascular Risk Variables
Speakers: Chee Kay Cheung, Neeraj Dhaun, Matthew Graham-Brown, Siân Griffin, Bruce Hendry, Alexandra Howson, Radko Komers, Alex Mercer, Kelly Parke, Stephanie Moody, Matthew Sayer, Smeeta Sinha, Lisa Willcocks, Jonathan Barratt
Summary Page Coming Soon
Urinary Biomarker Analysis Reveals Rapid Intrarenal Anti-Inflammatory and Anti-Fibrotic Effects of Sparsentan in IgA Nephropathy in the SPARTAN Study
Speakers: Chee Kay Cheung, William A Barratt, Sulalita Chaki, Silpa Chinnakotla, Neeraj Dhaun, Siân Griffin, Bruce Hendry, Amal A A Jama, Wenjun Ju, Ishika Khan, Radko Komers, Alex Mercer, Viji Nair, Nadia Nawaz, Matthew Sayer, Smeeta Sinha, Lisa Willcocks, Matthias Kretzler, Jonathan Barratt
Sparsentan Decreases Mesangial IgA Deposition in gddY Mice; A Possible Role for Mesangial-Cell-Surface Autoantigen Expression
Speakers: Kazuaki Mori, Yoshihito Nihei, Celia Jenkinson, Bruce Hendry, Hitoshi Suzuki, Yusuke Suzuki
MA-DS-25-0075 | August 2025